Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

1.68
+0.05003.07%
Post-market: 1.680.00000.00%17:37 EDT
Volume:7K
Turnover:11.29K
Market Cap:28.44M
PE:-0.03
High:1.75
Open:1.75
Low:1.64
Close:1.63
52wk High:20.99
52wk Low:1.58
Shares:16.93M
Float Shares:2.15M
Volume Ratio:0.06
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-50.6904
EPS(LYR):-52.5900
ROE:-59.28%
ROA:-19.90%
PB:-1.03
PE(LYR):-0.03

Loading ...

Transcode Therapeutics reports updated results from Phase 1a TTX-MC138 trial

TIPRANKS
·
Sep 28

TransCode Says Phase 1a Trial Shows 71.4% Stable Disease Rate for TTX-MC138 in Advanced Solid Tumors

Reuters
·
Sep 28

Transcode Reports Continued Disease Stabilization and Extended Treatment Duration with Ttx-Mc138 in Ongoing Phase 1a Clinical Trial Follow-up

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - Three Patients Remain Progression-Free at One Year

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - no Dose-Limiting Toxicities Reported Across Evaluated Dose Levels

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - 57.1% Disease Control Rate Through Three Months of Therapy

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - 71.4% Stable Disease Rate in 14 Efficacy-Evaluable Patients

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - Primary Endpoint of Phase 1a Study Met

THOMSON REUTERS
·
Sep 28

Transcode Therapeutics - Announces Patent Advancements in Australia and Japan for Rna Platform

THOMSON REUTERS
·
Sep 22

TransCode Therapeutics Says Australia Accepts Patent Application for siRNA Cancer Nanoparticle Delivery

Reuters
·
Sep 22

Transcode Therapeutics Names Interim CFO John A. Tattory in Initial Beneficial Ownership Filing

Reuters
·
Sep 22

TransCode Therapeutics Announces CFO Resignation and Interim Appointment

TIPRANKS
·
Sep 12

TransCode Therapeutics Appoints John Tattory as Interim CFO

Reuters
·
Sep 11

TransCode Therapeutics CFO Tom Fitzgerald Retires; John Tattory Named Interim CFO

Reuters
·
Sep 11

Transcode Therapeutics - Appoints John Tattory as Interim Chief Financial Officer Effective Immediately

THOMSON REUTERS
·
Sep 11

Transcode Therapeutics Announces Leadership Transition

THOMSON REUTERS
·
Sep 11

Press Release: TransCode Therapeutics Announces Leadership Transition

Dow Jones
·
Sep 11

TransCode Says Preclinical Study Shows Survival Benefit for TTX-MC138 in Breast Cancer Bone Metastasis Model

Reuters
·
Aug 31

Tempest Therapeutics Names Nicholas Rossettos CFO, Replacing Justin Trojanowski

Reuters
·
Aug 25

Transcode Therapeutics Says DEFJ LLC Files Initial Beneficial Ownership Statement

Reuters
·
Aug 06